TIRZEPATIDE : THE COMPARATIVE REVIEW

The novel class of GLP-1 receptor and GIP co-agonist medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, offer promising improvements in diabetes control. While all three function by influencing sugar levels , they distinguish in their unique mechanisms of performanc